Valuation: Haemonetics Corporation

Market Cap 4.79B 4.2B 3.97B 3.62B 6.77B 459B 6.82B 47.51B 18.4B 235B 17.99B 17.6B 754B P/E 2027 *
26.6x
P/E 2028 * 23.4x
Enterprise Value 5.45B 4.78B 4.52B 4.12B 7.71B 523B 7.76B 54.08B 20.95B 267B 20.47B 20.03B 858B EV / Sales 2027 *
3.85x
EV / Sales 2028 * 3.42x
Free-Float
98.74%
Yield 2027 *
0.95%
Yield 2028 * -
1 day-0.66%
1 week-2.86%
Current month+2.16%
1 month-1.22%
3 months+36.24%
6 months+89.66%
Current year+31.38%
1 week 104.71
Extreme 104.71
110.28
1 month 100.53
Extreme 100.53
110.45
Current year 51
Extreme 51
110.45
1 year 47.56
Extreme 47.555
110.45
3 years 47.32
Extreme 47.315
110.45
5 years 43.5
Extreme 43.5
110.45
10 years 32.76
Extreme 32.76
142.11
Manager TitleAgeSince
Chief Executive Officer 62 2016-05-15
Director of Finance/CFO 55 2022-04-10
Chief Operating Officer 56 2025-03-31
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Director/Board Member 62 2016-05-15
Director/Board Member 71 2017-10-17
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/26 Free

Director

2,538 0.0056%
7/24/26 Free

Director

2,538 0.0056%
7/24/26 Free

Director

2,538 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-2.86%+118.60%+19.33% 4.79B
+0.22%-1.29%-24.16%+5.26% 175B
+0.97%-3.79%-5.92%+12.27% 113B
-0.95%-0.60%-0.03%+65.22% 58.57B
+2.56%+1.59%-0.42%-29.55% 50.07B
+1.49%+3.89%+15.12%+53.65% 49.92B
-0.97%-3.06%+29.09%-2.26% 32.69B
+0.12%+9.67% - - 30.44B
-0.85%+2.24%+41.65%-1.32% 26.07B
-1.58%+7.22%+23.81%-6.14% 23.55B
Average +0.04%+1.40%+21.97%+12.94% 56.48B
Weighted average by Cap. +0.36%-0.02%-1.89%+13.42%

Financials

2027 *2028 *
Net sales 1.42B 1.24B 1.17B 1.07B 2B 136B 2.02B 14.05B 5.44B 69.38B 5.32B 5.2B 223B 1.5B 1.31B 1.24B 1.13B 2.11B 143B 2.13B 14.83B 5.74B 73.22B 5.61B 5.49B 235B
Net income 177M 156M 147M 134M 251M 17B 253M 1.76B 682M 8.69B 666M 652M 27.92B 207M 182M 172M 157M 293M 19.86B 295M 2.06B 796M 10.15B 778M 761M 32.61B
Net Debt 662M 581M 549M 500M 936M 63.45B 943M 6.57B 2.54B 32.42B 2.49B 2.43B 104B 327M 287M 271M 247M 462M 31.35B 466M 3.24B 1.26B 16.02B 1.23B 1.2B 51.48B
Logo Haemonetics Corporation
Haemonetics Corporation is a medical technology company. Its solutions address critical medical needs, which includes a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers, and products to enable blood centers to collect in-demand blood components. Its Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. Its Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies (Hemostasis Management, Cell Salvage and Transfusion Management products). It also offers solutions for structural heart and endovascular procedures.
Employees
3,009
Date Price Change Volume
26-09-25 US$105.30 -0.66% 492,604
26-09-24 US$106.00 -0.77% 416,799
26-09-23 US$106.82 -1.57% 704,878
26-09-22 US$108.52 -0.19% 446,603
26-09-21 US$108.73 +0.30% 327,026
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
105.30USD
Average target price
111.50USD
Spread / Average Target
+5.89%

Quarterly revenue - Rate of surprise